{
  "pmid": "38407434",
  "title": "Deucravacitinib: is there still a place or a need for a new oral agent?",
  "abstract": "",
  "pub_date": "2024-04-17",
  "publication_types": [
    "Editorial",
    "Comment"
  ],
  "affiliations": [
    "Istituto Dermopatico dell'Immacolata (IDI)-IRCCS, Rome.",
    "Dermatology Unit, Department of Medicine, University of Padua, Italy."
  ],
  "url": "https://pubmed.ncbi.nlm.nih.gov/38407434/",
  "snapshot_id": "2026-02-12T15-06-31Z",
  "ingested_at": "2026-02-12T15:06:35.632022+00:00"
}